Ibutilide

Potentially Fatal Arrhythmias

Experienced Personnel/Equipped Facility

Potentially Fatal Arrhythmias: have occurred and requires administration in a setting of continuous ECG monitoring and personnel trained in identification and treatment of acute ventricular arrhythmias.

Patient Selection: Patients with chronic atrial fibrillation have a strong tendency to revert after conversion to sinus rhythm and treatment to maintain sinus rhythms carry risks. Patients for ibutilide therapy should be carefully selected.

Monitoring data

  • Patients with atrial fibrillation of > 2 to 3 days must be adequately anticoagulated for > 2 weeks
  • Assess benefit/risk ratio of maintenance therapy

Patient counseling

Package inserts

Additional information

Updated: January 2018